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Abstract
 
Immunoglobulin class switch recombination (Ig CSR) involves DNA double strand breaks
(DSBs) at recombining switch regions and repair of these breaks by nonhomologous end-joining.
Because the protein kinase ataxia telengiectasia (AT) mutated (ATM) plays a critical role in
DSB repair and AT patients show abnormalities of Ig isotype expression, we assessed the role of
ATM in CSR by examining ATM-deficient mice. In response to T cell–dependent antigen
(Ag), 
 
Atm
 
   
 
 mice secreted substantially less Ag-specific IgA, IgG1, IgG2b, and IgG3, and less
total IgE than 
 
Atm
 
   
 
 controls. To determine whether 
 
Atm
 
   
 
 B cells have an intrinsic defect
in their ability to undergo CSR, we analyzed in vitro responses of purified B cells. 
 
Atm
 
   
 
 cells
secreted substantially less IgA, IgG1, IgG2a, IgG3, and IgE than wild-type (WT) controls in
response to stimulation with lipopolysaccharide, CD40 ligand, or anti-IgD plus appropriate
cytokines. Molecular analysis of in vitro responses indicated that WT and 
 
Atm
 
   
 
 B cells
produced equivalent amounts of germline IgG1 and IgE transcripts, whereas 
 
Atm
 
   
 
 B cells
produced markedly reduced productive IgG1 and IgE transcripts. The reduction in isotype
switching by 
 
Atm
 
   
 
 B cells occurs at the level of genomic DNA recombination as measured
by digestion–circularization PCR. Analysis of sequences at CSR sites indicated that there is
greater microhomology at the 
 
 
 
–
 
 
 
1 switch junctions in ATM B cells than in wild-type B cells,
suggesting that ATM function affects the need or preference for sequence homology in the
CSR process. These findings suggest a role of ATM in DNA DSB recognition and/or repair
during CSR.
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Introduction
 
The production of Ig isotypes other than IgM and IgD is
accomplished by a deletional recombination event that
brings a downstream C
 
H
 
 gene into proximity with V(D)J
elements, resulting in generation of antibodies of different
isotypes and effector function, but with unaltered antigen
(Ag) specificity. In this process of class switch recombination
(CSR), intrachromosomal recombination occurs between
tandemly repeated switch (S) region sequences located up-
stream of each Ig heavy chain constant region gene, with
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excision of intervening sequences in the form of circular
DNA.
CSR involves the induction of DNA breaks in S
 
 
 
 and a
downstream target S region, followed by ligation through a
nonhomologous end-joining (NHEJ) mechanism. In this
process, activation-induced cytidine deaminase (AID) is
clearly required, but the precise mechanism of its action is
not certain. A widely accepted model is that AID initiates
CSR by deamination of cytidine residues in the Ig S re-
gions to uracils; the resulting guanosine/uracil mismatches
are recognized by uracil–DNA glycosylase and excised, ul-
timately leading to DNA double strand breaks (DSBs; ref-
erences 1–4). An alternative model is that AID deaminates
cytidines in specific mRNA molecules, and edited mRNAs
encode an endonuclease that cleaves S regions, producing
DSBs (5). In either model, recognition and repair of these
DSBs are critical for successful completion of CSR.
The ataxia telengiectasia (AT) mutated (ATM) protein is
known to play a critical role in early events of sensing and
responding to DNA damage induced by insults such as ion-
izing radiation. The ATM protein is a member of a family
of phosphatidylinositol 3-kinase–related proteins that are
involved in cellular functions, including cell cycle regula-
tion, telomere length monitoring, meiotic recombination,
and DNA repair (6). In the presence of DNA damage,
ATM phosphorylates a variety of protein targets, including
p53 (7–9), CHK2 (10, 11), MDM2 (12, 13), BRCA1 (14,
15), and NBS1 (16–18), and activates multiple signal trans-
duction pathways (19, 20).
The precise mechanism of ATM activation in response
to DSBs is unknown but recent evidence suggests that in
the absence of DNA damage, ATM is held inactive as a
dimer, distributed throughout the nucleus (21). Generation
of DSBs induces rapid intermolecular autophosphorylation
of serine 1981 that causes dimer dissociation and allows ac-
cessibility of substrates to the ATM kinase domain (21).
Lee and Paull recently reported that a complex containing
Mre11, Rad50, and Nbs1 proteins stimulates the kinase ac-
tivity of ATM by facilitating the stable binding of substrates
(22). Visualization of ATM after DNA damage showed nu-
clear aggregates of ATM staining, which colocalized with
foci of two proteins previously shown to localize to sites of
DNA damage: NBS1 and the phosphorylated form of
H2AX, known as 
 
 
 
-H2AX (23). Perkins et al. used chro-
matin immunoprecipitation to show that ATM also local-
izes to breaks associated with V(D)J recombination, both in
the Ig
 
 
 
 locus in a pre–B cell line, and in the TCR
 
 
 
 locus
in primary mouse thymocytes (24). These observations
suggest that ATM may play a functional role in T and B
cell V(D)J recombination. Consistent with this view, the
absence of ATM in AT patients or in genetically engi-
neered ATM-knockout mice results in lymphomas caused
by aberrant V(D)J recombination and translocation in de-
veloping thymocytes (25–30), probably reflecting failure of
normal recombination repair. The observed abnormalities
in expression of switched Ig isotypes and alterations in S–S
junction sequences in humans with ATM defects (31–34)
suggest that ATM may also participate in Ig isotype switch-
ing. We have used a mouse model of ATM deficiency to
study the role of ATM in Ig class switching, and have iden-
tified and characterized a defect in CSR that is intrinsic to
B cells and suggests a role of the 
 
Atm
 
 gene product in DNA
DSB recognition and/or repair during CSR.
 
Materials and Methods
 
Mice. Atm
 
   
 
 mice were generated by introducing a trunca-
tion mutation into the gene at nucleotide 5790 (27). Progeny of
heterozygous matings were genotyped by PCR (35). All mice
used in this study were 7–12-wk-old, and 
 
Atm
 
   
 
 littermates
were used as controls. All animal experiments were approved by
the National Cancer Institute Animal Care and Use Committee.
 
In Vivo Immunization. 
 
Mice were immunized i.p. with 100
 
 
 
g TNP-KLH in Imject alum (Pierce Chemical Co.), and serum
was collected on day 0 before immunization and on days 7, 14,
21, and 39 after immunization. Mice were boosted in the same
manner on day 40, and serum was collected on day 8. To assay
Ag-specific IgA responses, mice were immunized via intragastric
instillation with 1 mg TNP-KLH and 10 
 
 
 
g cholera toxin (List
Biological Laboratories, Inc.) in 0.2 M NaHCO
 
3
 
. Mice were
boosted in the same manner on day 22, and serum was collected
on day 4 after rechallenge. Total and Ag-specific serum Ig were
assayed by ELISA.
 
Ab Detection by ELISA. 
 
Total IgA, IgG1, IgG2a, IgG2b,
IgG3, IgM, or IgE were captured with purified goat anti–mouse
IgA, IgG1, IgG2a, IgG2b, IgG3, IgM, or IgE (Southern Biotech-
nology Associates, Inc.) and detected with horseradish peroxidase
(HRP)–conjugated goat anti–mouse 
 
 
 
, 
 
 
 
1, 
 
 
 
2a, 
 
 
 
2b, 
 
 
 
3, or
 
 
 
 (Southern Biotechnology Associates, Inc.) or biotinylated rat
anti–mouse IgE, and HRP-conjugated streptavidin (Southern Bio-
technology Associates, Inc.). To measure Ag-specific Ig, plates
were coated with 2.5 
 
 
 
g/well TNP-OVA, and Ig was detected
with HRP-conjugated anti-
 
 
 
, 
 
 
 
, 
 
 
 
1, 
 
 
 
2a, 
 
 
 
2b, or 
 
 
 
3. In all
cases, wells were developed with ABTS Microwell Peroxidase
Substrate System (Kirkegaard & Perry Laboratories), and OD was
measured at 405 nm. Titers were determined by interpolation of
the dilution of serum that gave a 50% OD of the maximum ab-
sorbance achieved.
 
Purification and In Vitro Activation of B Cells.
 
Enriched popula-
tions of splenic B cells were obtained using magnetic CD19 beads
according to the manufacturer’s instructions (Miltenyi Biotec). 2 
 
 
 
10
 
5
 
 cells were cultured in 24-well flat-bottom plates in 1 ml of
complete medium consisting of RPMI 1640 (Biowhitaker) supple-
mented with 10% fetal calf serum (Biofluids), 1% sodium pyruvate,
1% nonessential amino acids, 0.5% 
 
l
 
-glutamine, 5 
 
 
 
 10
 
 
 
5
 
 M
2-mercaptoethanol, 100 U/ml penicillin, and 100 
 
 
 
g/ml strepto-
mycin and incubated at 37
 
 
 
C in a humidified atmosphere contain-
ing 5% CO
 
2
 
. To induce specific isotype switching, B cells were
stimulated with the following: for IgE, IgG1, IgG2a, and IgM, 2.15
 
 
 
g/ml mouse membrane CD40 ligand (CD40L; provided by M.
Kehry, Idec Pharmaceuticals, San Diego, CA; reference 36) and
1,000 U/ml recombinant mouse IL-4 (prepared from a baculovirus
expression system in our laboratory); for IgG2b and IgG3, 15 
 
 
 
g/
ml LPS (Sigma-Aldrich); and for IgA, 2.15 
 
 
 
g/ml CD40L, 1,000
U/ml IL-4, 150 U/ml IL-5, 10 ng/ml TGF-
 
 
 
 (provided by A.
Roberts, National Institutes of Health, Bethesda, MD), and 3 ng/
ml anti-IgD dextran (a gift from C. Snapper, Uniformed Services
University of the Health Sciences, Bethesda, MD). Supernatants
were harvested on day 6 for quantitation of Ig by ELISA. 
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Surface Ig Expression. 
 
Resting splenic B cells were isolated
and stimulated to induce IgG1/IgE production as described be-
fore and cells were harvested at varying time points after activa-
tion. Surface IgG1 expression was detected with biotin-conju-
gated goat anti–mouse IgG1 Ab and CyChrome conjugate (BD
Biosciences). Surface IgE was detected with FITC-conjugated rat
anti–mouse IgE mAb R1.E4 (provided by C. Snapper). This Ab
recognizes an IgE epitope that is masked when IgE is bound to
Fc
 
 
 
RII; therefore, it reacts with intrinsic transmembrane IgE, but
not cytophilic IgE, and can be used for quantitation of IgE-pro-
ducing B cells. The specificity of anti-IgG1 and anti-IgE staining
was verified by demonstrating that staining with each reagent was
specifically inhibited by unlabeled Ab specific for the correspond-
ing isotype. Samples were analyzed on a Becton Dickinson
FACScan, and data were analyzed with CELLQuest software.
 
CFSE Staining. 
 
Cells were washed and resuspended at 10
 
7
 
cells/ml in PBS at room temperature. An equal volume of 10
 
 
 
M CFSE (Molecular Probes) in PBS was added to the cell sus-
pension, which was immediately vortexed and incubated for 8
min at room temperature. Unbound dye was quenched by the
addition of an equal volume of FCS, and cells were washed three
times with ice-cold complete medium. Cells were cultured under
the conditions described before to induce class switching, har-
vested at various time points after activation, and analyzed using a
Becton Dickinson FACScan.
 
Quantitative Real-Time RT-PCR. 
 
RNA was extracted from
cultured cells with TRIzol, as described by the supplier (Invitro-
gen). Approximately 1 
 
 
 
g RNA was used to generate cDNA us-
ing SuperScript II reverse transcriptase and random hexamers (In-
vitrogen). The resulting cDNA was used in quantitative real-time
PCR reactions using an ABI 7900HT machine and ABI 2X
SYBR green Master Mix. Amplification of GAPDH was used for
sample normalization, and quantification of gene expression rela-
tive to GAPDH was performed using the 
 
  
 
CT methods as de-
scribed by the manufacturer (Sequence Detector User Bulletin 2;
Applied Biosystems). PCR primers used for these analyses are
as follows: germline IgG1, G
 
 
 
1, 5
 
 
 
-TCGAGAAGCCTGAGG-
AATGT-3
 
 
 
 and 5
 
 
 
-ATAGACAGATGGGGGTGTCG-3
 
 
 
; germ-
line IgE, G
 
 
 
, 5
 
 
 
-CTGGCCAGCCACTCACTTAT-3
 
 
 
 and 5
 
 
 
-
CAGTGCCTTTACAGGGCTTC-3
 
 
 
; productive IgG1, P
 
 
 
1,
5
 
 
 
-TCGAGAAGCCTGAGGAATGT-3
 
 
 
 and 5
 
 
 
-ATAGACAG-
ATGGGGGTGTCG-3
 
 
 
; productive IgE, P
 
 
 
, 5
 
 
 
-TTGGACTA-
CTGGGGTCAAGG-3
 
 
 
 and 5
 
 
 
-CAGTGCCTTTACAGGGC-
TTC-3
 
 
 
; GAPDH, 5
 
 
 
-TGCACCACCAACTGCTTAG-3
 
 
 
 and
5-CGCCGCTAGAGGTGAAATTCT-3
 
 
 
. All quantitative real-
time PCR reactions were performed two times in triplicate.
 
Digestion–Circularization-PCR (DC-PCR). 
 
Genomic DNA
was isolated from cultured B cells using a DNA isolation kit
(QIAGEN) according to the manufacturer’s instructions. 1 
 
 
 
g
DNA was digested with EcoRI (New England Biolabs, Inc.)
overnight and 100 ng was ligated overnight with T4 DNA ligase
in a volume of 50 
 
 
 
l (New England Biolabs, Inc.). Ligated DNA
was subjected to two rounds of PCR using nested primer
pairs for S
 
 
 
–S
 
 
 
1, S
 
 
 
–S
 
 
 
, and nicotinic acetylcholine receptor
(nAChR) DC-PCR. Primers for the first round of PCR were as
follows: S
 
 
 
–S
 
 
 
1, 5
 
 
 
-GAGCAGCTACCAAGGATCAGGGA-3
 
 
 
and 5
 
 
 
-CTTCACGCCACTGACTGACTGAG-3
 
 
 
; S –S ,
5 -CGGGTATTGGAAAATAATTGAATG-3  and 5 -GCAG-
AGCATCCTCACATACA-3 ; and nAChR, 5 -GCAAACAG-
GGCTGGATGAGGCTG-3  and 5 -GTCCCATACTTAGA-
ACCCCAGCG-3 . For S –S 1 and nAChR amplification,
conditions were 5 cycles at 94 C for 1 min, 65 C for 1 min, and
72 C for 2 min; and 30 cycles at 94 C for 1 min, 68 C for 1 min,
and 72 C for 2 min. Amplification conditions for S –S  were 35
cycles at 94 C for 1 min, 55 C for 1.5 min, and 72 C for 2 min.
Primers for the second round of PCR were as follows: S –S 1,
5 -GGAGACCAATAATCAGAGGGAAG-3  and 5 -GAGAG-
CAGGGTCTCCTGGGTAGG-3 ; S –S , 5 -GTCCTTCAA-
TTTCTTACATAACC-3  and 5 -ATGCAGGATAGACCCC-
AGAC-3 ; and nAChR, 5 -GGACTGCTGTGGGTTTCAC-
CCAG-3  and 5 -GCCTTGCTTGCTTAAGACCCTGG-3 .
PCR conditions for S –S 1 and nAChR were the same as for
the first round, and conditions for S –S  were 30 cycles at 94 C
for 1 min, 57 C for 1.5 min, and 72 C for 2 min.
Switch Junction Analysis. S –S 1 junctions were amplified
from genomic DNA from CD40L–IL-4–stimulated B cells using
Expand long template PCR system (Roche) and primers 5 3,
5 -AATGGATACCTCAGTGGTTTTTAATGGTGGGTTTA-
3  and  1-R, 5 -CAATTAGCTCCTGCTCTTCTGTGG-3 .
Amplification conditions were 35 cycles at 95 C for 30 s, 58 C
for 45 s, and 72 C for 2 min and 30 s. PCR products (500–1,000
bp) were gel extracted, cloned using TA cloning kit (Invitrogen),
and sequenced using 5 3 and  1-R primers. Sequence analysis
was performed using DNASTAR software.
Hypermutation Analysis.  For V Ox1 genes, three Atm-defi-
cient mice were immunized i.p. with phenyloxazolone coupled
to chicken serum albumin in adjuvant. Mice were killed 4 d after
the secondary injection, and spleens were removed. B cells that
bound phycoerythrin-labeled antibody to B220 (BD Biosciences)
and fluorescein-labeled peanut agglutinin (PNA; E-Y laborato-
ries) were isolated by flow cytometry. DNA from B220 PNA 
cells was amplified using primers that included 190 bases of 5 
intron sequence, the V Ox1 coding sequence, and the J 5 gene
segment (37). Amplified products were cloned into pBluescript
and sequenced. For S  regions, one Atm    mouse and litter-
mate control were immunized with TNP-KLH and killed after
the second injection. DNA from B220 PNA  spleen cells was
amplified using primers for a 561-bp region located upstream
of the S  core region (38) and sequenced. PCR error was de-
termined by sequencing similar regions from nonactivated B
cells (0.4   10 4 mutations/bp; 1 mutation per 24,963 nu-
cleotides). Two-sided p-values were determined to compare
frequencies.
Results
Ig Production Is Impaired in Atm-deficient Mice.  It has
been reported that AT patients have deficiencies in serum
IgA, IgE, IgG2, and IgG4 levels (31, 32, 39–42). To assess
the role of ATM in Ig class switching, basal serum Ig levels
of different isotypes were therefore assessed in unimmu-
nized Atm    mice. Levels of IgA, IgG2b, and IgM were
not significantly different in Atm    and Atm    (Fig. 1 A).
However, Atm    mice had significantly lower levels of
IgG1, IgG2a, and IgG3 than wild-type mice (Fig. 1 A). IgE
was undetectable in both normal and mutant mice (unpub-
lished data). The immune competence of Atm    mice for
T cell–dependent (TD) antibody responses was assessed by
measuring the in vivo response to challenge with TNP-
KLH in alum. There was no difference in Ag-specific IgM
responses of Atm    and Atm    mice (Fig. 1 B). In con-
trast, the Ag-specific IgG1 response in Atm    mice was
16–38-fold lower than the WT controls at all the time
points tested (Fig. 1 C). To detect production of other iso-Atm Function in Ig Class Switch Recombination 1114
types, the mice received a second immunization of Ag, and
serum was collected at day 8 after rechallenge. Significant
Ag-specific IgG2b and IgG3 responses were detected in
WT mice, but not in Atm-deficient mice (Fig. 1 D). Levels
of Ag-specific IgA, IgE, and IgG2a were low or undetect-
able in all mice tested in response to this immunization
(unpublished data). Because we could not detect Ag-spe-
cific IgE in response to immunization (unpublished data),
we measured total IgE serum levels at day 8 after a second-
ary immunization. Levels of IgE were low or undetectable
in unimmunized mice (not depicted), but increased signifi-
cantly after immunization of WT mice (Fig. 1 D). In con-
trast, an IgE response was not detected in Atm    mice. To
detect Ag-specific IgA, mice were immunized via gastric
feeding to stimulate a mucosal response. Ag-specific IgA
was found in WT mice at day 4 after a secondary immuni-
zation, whereas it was low or undetectable in KO mice
(Fig. 1 E). These results suggest that Atm    mice have a
defect in CSR after immunization with a TD Ag.
In Vitro Secretion of Class-switched Isotypes Is Defective in
Atm-deficient B Cells.  To examine the intrinsic ability of
Atm    B cells to undergo CSR in vitro, splenic B cells were
cultured with various polyclonal B cell activators (43) and
levels of IgA, IgG1, IgG2b, IgG3, IgE, and IgM were mea-
sured in day 6 supernatants. The unswitched IgM response
of Atm    B cells was minimally reduced relative to WT
controls (82% of control titers), whereas switched isotypes
were affected to different degrees (Fig. 2). Most affected was
the IgE response, which was undetectable in Atm    B cell
undetectable in Atm    mice. Results are representative of two indepen-
dent experiments. (E) Serum levels of Ag-specific IgA were measured in
mice (five per group) immunized with TNP-KLH p.o., and serum was
collected 4 d after the second immunization.
Figure 1. Impaired Ig production in Atm    mice. (A) Sera from eight
Atm-deficient mice and littermate controls were assayed for total Ig levels
by ELISA. IgE was undetectable by ELISA in sera from unimmunized mice.
Results are displayed as the mean   SEM Atm    titer as a percentage of the
Atm    controls. (B–D) Three Atm /  mice and their WT littermates
were immunized with TNP-KLH/Alum i.p., and serum was collected at
the indicated time points. Serum levels of Ag-specific IgM (B) and IgG1
(C) were assayed by ELISA; data points represent the geometric mean  
geometric SEM of the ELISA titers. (D) Mice received a second immuni-
zation of TNP-KLH/Alum 40 d after the first immunization, and serum
was collected after 8 d. Serum levels of total IgE and Ag-specific IgG2b
and IgG3 were assayed by ELISA, and data points are displayed as the
mean   SD Atm    titer as a percentage of the Atm    controls. The
dotted line indicates the limit of detection. IgE, IgG2b, and IgG3 were
Figure 2. Defective Ig production in Atm    B cells activated in vitro.
CD19  B cells were isolated from the spleens of Atm    and WT mice
and cultured with CD40L and IL-4 (IgG1, IgG2a, and IgM), CD40L,
IL-4, IL-5, TGF- , and anti-IgD dextran (IgA) or LPS (IgG2b, IgG3).
Results are displayed as the mean of three to four experiments   SEM
Atm    titer as a percentage of the Atm    controls.Lumsden et al. 1115
cultures ( 1% of WT responses), and IgG1, for which
Atm    B cells produced 7% of the levels in WT B cell cul-
tures. IgA, IgG2a, and IgG3 were all significantly lower in
Atm    cultures. IgG2b responses were not significantly re-
duced, in contrast with the reduction in Ag-specific IgG2b
production observed in vivo (Fig. 1 D). To determine
whether the decrease in IgG1 and IgE secretion by in vitro–
stimulated Atm-deficient B cells resulted from an altered fre-
quency of cells undergoing CSR or reflected only decreased
production of Ig per isotype-switched cell, we examined
surface Ig by flow cytometry. After 4 d of in vitro activation,
surface IgG1 was expressed by 38% of Atm    B cells, and
surface IgE was expressed by 5.3% of Atm    B cells (Fig. 3).
In contrast, IgG1 was expressed by only 9% of Atm    B
cells and there was little or no detectable expression of IgE
by Atm    B cells. Thus, the observed in vivo and in vitro
deficiencies in Ig secretion in Atm    mice and cells appear
to be due to an intrinsic B cell defect in CSR.
The Ig CSR Deficiency in Atm    B Cells Is Not Due to Al-
tered Clonal Expansion.  The generation of class-switched
B cells is dependent on cellular proliferation through at
least two effects. First, it has been reported that the CSR
process itself requires cellular proliferation (44). In addition,
B cells undergo clonal expansion after CSR, and the num-
ber of class-switched cells detected after a B cell response
will be determined by the degree of this clonal expansion.
To determine whether the reduced switching observed in
Atm    B cells could be explained by a defect in cell prolif-
eration, we combined cytoplasmic dye dilution with flow
cytometric staining of surface Ig isotypes to measure clonal
expansion of switched and nonswitched cells. In the ab-
sence of surface IgE expression by Atm    B cells (Fig. 3), it
was not possible to assess the effect of Atm deletion on
Figure 3. Surface Ig expression of IgG1 and IgE isotypes on in vitro–
stimulated wild type and Atm    B cells. Cells were harvested after 4 d of
in vitro stimulation with CD40L and IL-4, and flow cytometric analysis
was used to determine surface IgG1 and IgE expression. Numbers on the
dot plots show the percentage of switched cells as a proportion of B220 
B cells. Results are representative of four independent experiments.
Figure 4. Clonal expansion of IgG1-switched B cells. CFSE-stained
resting B cells were stimulated in vitro with CD40L and IL-4 for 3–6 d
and counterstained with goat anti–mouse IgG1 as described in Materials
and Methods. (A) CFSE staining profiles of Atm    and Atm    B cells
are presented in the first two columns. The third column shows the per-
centage of recovered Atm    and Atm    cells that have undergone the
indicated number of cell divisions. (B) Two-color flow cytometric pro-
files indicate IgG1 expression on CFSE stained cells. The percentage of B
cells expressing IgG1 is indicated for Atm    B cells and Atm    B cells
that have undergone the indicated numbers of cell divisions. Results are
representative of three independent experiments.Atm Function in Ig Class Switch Recombination 1116
clonal expansion of IgE-switched cells. However, it was
possible to carry out a comparison of IgG1 switching and
clonal expansion in Atm    and Atm    B cells. Resting
splenic B cells from Atm    and control mice were labeled
with CFSE and activated in vitro with CD40L and IL-4.
At multiple time points after stimulation, cells were har-
vested and counterstained for surface IgG1 expression. Di-
lution of intracellular CFSE staining allowed quantitative
assessment of cell division, whereas surface Ig staining al-
lowed identification of IgG1-switched B cells. A modest
decrease in cell division was observed in the response of
Atm    B cells to CD40L and cytokines, as reflected by a
higher proportion of Atm    cells that had undergone
fewer cell divisions as compared with Atm    cells (Fig. 4
A). In both Atm    and Atm    B cells, surface expression
of IgG1 increased with increasing number of cell divisions
(Fig. 4 B). Moreover, the percentage of IgG1 positive B
cells was two- to threefold greater in the population of
Atm    B cells that had undergone three to six divisions
than for the population of Atm    B cells that had under-
gone an identical number of divisions. These results indi-
cate that a class switch defect, independent of differences in
clonal expansion, is the predominant determinant of de-
creased IgG1-switched cells seen in Atm    mice.
Germline Transcripts Are Normal, but Productive Transcripts
Are Impaired in Atm-deficient B Cells.  To assess the molec-
ular mechanisms involved in the defective CSR to IgG1
and IgE observed in Atm    B cells, we examined the ex-
pression of germline (G 1, G ) and productive (P 1 and
P ) transcripts by real-time RT-PCR. Resting B cells from
Atm    and control spleens were activated in vitro with
CD40L and IL-4, and total RNA was isolated from cells
harvested at days 3 and 6. Both G 1 and G  transcripts
peaked on day 3 for stimulated B cells from WT cells,
whereas P 1 and P  transcripts peaked at day 6 (Fig. 5 and
not depicted). Similar amounts of G 1 and G  transcripts
were induced in Atm    B cells and controls (Fig. 5) indi-
cating that Atm    B cells were competent to respond to
signals delivered by CD40L and cytokines. In contrast, the
expression of P 1 and P  transcripts in Atm    B cells was
markedly reduced, with amplified P 1 transcripts being 14-
fold lower and P  transcripts 60-fold lower than normal
controls. These data suggest that ATM has a role down-
stream of germline transcription.
Atm-deficiency Reduces Class Switching at the Level of DNA
Recombination.  To determine directly whether the de-
crease in isotype switching occurs at the level of DNA re-
combination, we used a quantitative DC-PCR assay (45)
to measure actual switch recombination. In B cells that
have undergone CSR, 5  S   sequences are contiguous
with 3  S 1 or S  on the recombined IgH allele. After
EcoRI digestion of genomic DNA, S  and S 1 or S  and
S  sequences therefore reside on the same DNA fragment
if switching to that isotype has occurred. To detect these
fragments, EcoRI-digested genomic DNA was ligated un-
der conditions that promote circularization, and the region
spanning the ligated EcoRI junctions was amplified by a
PCR strategy that produces PCR products of uniform size,
independent of where recombination took place within the
S region (45). Primers specific for a control EcoRI frag-
ment that does not undergo rearrangement (nAChR) were
Figure 5. Real-time RT-PCR analysis of germline and productive
IgG1 and IgE transcripts in Atm    B cells activated in vitro. Total RNA
was isolated from B cells activated in vitro, and quantitative real-time
RT-PCR was performed as described in Materials and Methods. Germ-
line transcripts were measured at day 3 of culture and productive tran-
scripts were measured at day 6 of culture. The data were normalized
to GAPDH and presented as the increase in transcript level over un-
stimulated wild-type B cells. The data shown are representative of two
independent experiments.
Figure 6. DC-PCR analysis of genomic switch recombination in wild
type and Atm    B cells. Genomic DNA was isolated from B cells activated
in vitro for 6 d, digested with EcoRI, and ligated with T4 DNA ligase.
Twofold serial dilutions were used as a template for DC-PCR using
primers specific for the recombined S regions. nAChR levels were also
determined by DC-PCR to control for equal template loading. The re-
sults shown are representative of two independent experiments.Lumsden et al. 1117
used to control for DNA input and efficiency of digestion
and circularization. DC-PCR analysis indicated that the
frequency of S –S 1 switch recombination in Atm    B
cells was at least 16-fold lower than in WT B cells (Fig. 6).
S –S  recombination in Atm    B cells was at least eight-
fold lower than in WT B cells. Thus, the reduction in iso-
type switching observed in Atm-deficient B cells reflects a
defect at the level of DNA recombination.
Analysis of CSR Junctions from Atm-deficient B Cells.
Although the efficiency of CSR is decreased in the absence
of ATM, some cells do succeed in producing IgG1 in re-
sponse to CD40L and IL-4. To determine whether these
CSR junctions were altered in the absence of ATM, we
compared IgG1 CSR junctions from Atm    (n   23 junc-
tions) and WT (n   31 junctions) B cells (Fig. 7). We
found a significant increase in the amount of donor–accep-
tor (S –S 1) homology at the switch junctions from Atm   
B cells; the average length of overlap was 2.6   0.5 bp in
the Atm    and 1.2   0.2 bp in control B cells (P   0.01,
Student’s t test). Thus, ATM function may affect the pref-
erence for sequence homology, as well as overall efficiency
of CSR.
Analysis of Hypermutation in V  and S Regions from Atm-
deficient B Cells.  To determine the effect of ATM defi-
ciency on another AID-dependent B cell–specific process,
we analyzed somatic hypermutation in V Ox1 genes
and switch regions. For selected V Ox1 genes from
Figure 7. S –S 1 switch recombination junctions from Atm    B
cells. Histogram depicting the percentage of sequences with the indicated
length of microhomology at S –S 1 junctions. Overlap was determined
by identifying the longest region at the switch junction of perfect unin-
terrupted donor/acceptor identity.
Figure 8. Hypermutation analyses in V  and S re-
gions from Atm-deficient mice. (A) Mutation in re-
arranged V Ox1 genes. The total number of clones
analyzed is shown in the center of each circle. The
pie segments represent the proportion of clones that
contained the specified number of mutations indi-
cated. (B) Mutation in upstream S  regions. (C) Muta-
tions near the S –S 1 junctions ( 50 bp). (D) Fre-
quencies of mutation. The number of mutations and
bases sequenced are shown in parentheses. Percent of
mutations at G and C bases was calculated after cor-
rection for base composition. p-values compare the
data for Atm    to Atm    clones. *, frequency of
Atm    S   clones is significantly higher than PCR
error (P   0.045).Atm Function in Ig Class Switch Recombination 1118
PNA B220  spleen cells from immunized mice (Fig. 8 A),
the frequency of mutation per basepair was lower in Atm   
clones (31   10 4) compared with Atm    clones (85  
10 4; P   10 3, Fisher’s exact test). However, the spectra
of base changes in Atm    clones (53 mutations; 55% at
G:C pairs) was similar to that from Atm    clones (111 mu-
tations; 49% at G:C pairs; P   0.77; Fig. 8 D). For unse-
lected S regions, the frequency of mutation per basepair
was not significantly different between the two groups of
clones in either upstream S  regions from PNA B220 
spleen cells (Atm   , 4   10 4; Atm   , 2.5   10 4; P  
0.22; Fig. 8 B) or within 50 nucleotides from the S –S 1
junctions from CD40L–IL-4–stimulated spleen cells (Atm   ,
87   10 4; Atm   , 87   10 4; Fig. 8 C). There was also
no significant difference in the frequency of substitutions at
G:C vs. A:T base pairs between the two groups of clones
(Fig. 8 D).
Discussion
ATM plays a critical role in pathways for repair of DNA
DSBs induced by insults such as gamma irradiation (46).
Studies have also indicated that Ig class switching involves
induction of DNA breaks and their resolution by NHEJ.
Thus, animals or cells that lack protein components of the
NHEJ pathway, such as Ku80, Ku70, or DNA-PKcs, have
major defects in class switching (47–49). To assess the role
that ATM may play in sensing and responding to DNA
DSBs generated during Ig heavy chain CSR, we examined
the in vivo and in vitro antibody responses of Atm-deficient
mice. Atm-deficient mice have reduced basal serum levels
of several IgG isotypes and generate markedly reduced ti-
ters of Ag-specific IgG1 and total IgE, as well as significant
decreases in Ag-specific IgA, IgG2b, and IgG3 compared
with WT controls after immunization with TD Ag. These
findings are parallel to the defect in class switching that is
observed in AT, where it is associated with a susceptibility
to recurrent infections (31, 32, 39–42).
Antibody responses to TD Ags require both intact B cell
function and T cell help. Although there is evidence for T
cell defects in AT patients (50, 51), our preliminary experi-
ments failed to identify a defect in T helper function in
Atm    mice as reflected by normal polarized maturation to
Th1 or Th2 cells producing IFN-  or IL-4, respectively
(unpublished data). Therefore, further studies focused on
an analysis of intrinsic B cell function in Atm-deficient
mice. In vitro activation of resting B cells with CD40L,
LPS, or anti-IgD in combination with appropriate cyto-
kines revealed a decrease in production of multiple class-
switched Ig isotypes by Atm    as compared with WT B
cells. Flow cytometric analysis of the cultured cells demon-
strated that there were fewer cells undergoing CSR in the
absence of ATM. Thus, when surrogate Th signals were
provided in vitro, Atm    B cells were markedly deficient
in switching to IgG1 and IgE, and significantly reduced in
switching to IgA, IgG2a, and IgG3 as well. These findings
suggested that the observed defects in Ig class switching are
intrinsic to Atm    B cells. Defects in polyclonal activation
of B cells from AT patients have also been shown to be B
cell intrinsic (52).
The production and secretion of Ig isotypes other than
IgM are accomplished by a deletional recombination event
that brings a downstream CH gene into proximity with
V(D)J elements. All intervening DNA, consisting of the CH
genes located between the V(D)J locus and the targeted CH
gene, is looped out and deleted. This switch recombination
is preceded by the production of a sterile germline tran-
script from the CH gene that is to be recombined. Germ-
line transcription appears to be essential for CSR. The
germline transcript may provide the DNA recombinatorial
machinery with access to the chromosomal region contain-
ing the CH gene to be expressed (53, 54) or the transcript
itself may participate in CSR by binding to the template
strand of the switch region, promoting a structure that is
accessible to the recombination machinery (4, 55). We
evaluated the role of clonal expansion of switched and
nonswitched B cells by flow cytometry and assayed G 1,
G , P 1, and P  mRNA by real-time RT-PCR. Normal
levels of G 1 and G  transcription were detected in Atm   
mice, indicating that Atm    B cells are capable of being
activated by CD40L and IL-4 and that the CSR defect
does not result from impaired germline transcription. How-
ever, a substantial reduction was observed in P 1 and
P  expression, suggesting that Atm    mice are defective in
 –  and  –  switch recombination and/or in the tran-
scription of successfully recombined IgH genes. Analysis of
genomic DNA by DC-PCR demonstrated a defect at the
level of DNA recombination. When clonal expansion was
measured by dye dilution in IgG1 class switched and un-
switched B cells, it was found that a class switch defect, in-
dependent of clonal expansion, is the predominant cause of
the observed deficiency in switched Atm    B cells. These
findings suggest a functional role of the Atm gene product
in switch recombination.
Several studies have suggested that ATM may be in-
volved in DNA damage repair, cell cycle regulation, and
meiotic recombination, all of which have in common the
response to DNA DSBs. The Atm gene product shows se-
quence similarity to the PI 3-kinase, and the catalytic sub-
unit of DNA-dependent protein kinase (DNA-PKcs). The
DNA–PK complex is thought to be activated by DNA
DSBs, resulting in binding of the Ku70–Ku80 heterodimer
followed by recruitment of DNA-PKcs to the complex.
Although Atm    mice resemble mice deficient in compo-
nents of the Ku–DNA–PK complex in being radiosensitive
and immunodeficient, the phenotypes are different in im-
portant respects. In the immune system, the Ku–DNA–PK
complex is required for both V(D)J rearrangement and Ig
CSR, and mice deficient in any of these components have
been reported to have defects in lymphocyte development.
In contrast, Atm    mice are competent for V(D)J rear-
rangement as reflected in the development of mature T and
B cell receptor repertoires. However, it is of interest that
many thymic lymphomas as well as nontransformed T cells
in these mice harbor abnormal translocations of the T cell
receptor  /  locus (30), suggesting that there may in factLumsden et al. 1119
be abnormalities in T cell receptor rearrangement in the
absence of the Atm product. Although ATM appears to be
required for optimal CSR to multiple isotypes, including a
marked influence on IgG1 responses, DNA-PKcs–deficient
B cells have been reported to be competent for class
switching to IgG1, but not other isotypes (56). Collec-
tively, these findings suggest that ATM and DNA–PK
mediate distinct but related functions in the molecular
mechanisms that underlie DNA DSB repair, V(D)J recom-
bination, and Ig CSR. The DNA damage–response factors
53bp1 and  -H2AX are also required for CSR but are dis-
pensable for V(D)J recombination (57–59). The defect in
CSR that is seen in B cells from 53bp1- or  -H2AX–defi-
cient mice is strikingly similar to that observed in Atm-defi-
cient B cells in that there is no defect in CH germline tran-
scription but impaired CSR. The relationship between
53bp1 and ATM may be complex (60). It has been re-
ported that phosphorylation of 53bp1 in response to DNA
damage is partially, but incompletely, dependent on ex-
pression of Atm, suggesting that 53bp1 can be phosphory-
lated by ATM or other kinases, such as ATR (61, 62).
The specific role of ATM proteins in events such as Ig
CSR may be related to their general function in recogni-
tion and response to DNA DSB. It has been reported that
Ig class switching occurs in cells undergoing proliferation
and that inhibition of DNA synthesis prevents switch re-
combination (63–65). Thus, it is important that any DNA
breaks be resolved to be compatible with DNA synthesis
and mitosis. Atm-deficient mice may have an abnormal
DNA damage surveillance program that results in failure to
repair cells with DSBs induced during the course of im-
mune gene rearrangements, through an inability to induce
cell cycle arrest until the completion of rearrangement re-
pair. Elucidation of the components involved in this recog-
nition should enhance our understanding of the mechanism
of isotype switching.
Sequence analyses of CSR events in Atm-deficient B
cells provided additional information regarding the func-
tion of ATM in these processes. The finding that sequence
homology at S –S 1 junctions is greater in Atm-deficient
mouse B cells than in WT controls is consistent with a re-
cent finding in B cells from AT patients (33), although the
effect that we have observed in mice appears to be less
marked than that in patients. This finding suggests that
ATM may either affect the site of initial DNA breaks in
switch regions or, perhaps more likely, may affect the effi-
ciency of break repair and splicing in the process of CSR.
Thus, the presence of ATM may increase overall efficiency
of repair, rendering it less dependent on a facilitating role of
switch region homology.
The observed decrease in CSR in Atm-deficient B cells
could be due to reduced activity of AID, the enzyme pro-
ducing strand breaks and hypermutation. Therefore, we
examined switch region sequences from PNA  B cells and
from in vitro–switched B cells and found no significant dif-
ference in the frequency of mutation between Atm-defi-
cient and proficient clones. This supports a role for ATM
in CSR after AID-induced lesions are introduced. There
was a small but significant, approximately twofold, decrease
in the frequency of somatic hypermutation in V Ox1 genes
in immunized Atm-deficient mice, although the types of
substitutions were similar to those from WT mice. Thus,
the ATM protein may not directly participate in the hyper-
mutation pathway, but may have an indirect role in influ-
encing the frequency of mutation. In Atm-deficient pa-
tients, a lower frequency of mutation in switch regions, but
not in VH genes, was observed in peripheral blood lympho-
cytes (34), and the basis for this difference from findings in
mice is not apparent.
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